Zyversa Therapeutics Inc (ZVSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ZVSA | AZN | AMGN | GILD | BMY |
| Company | Zyversa Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.1900 | 207.30 | 357.46 | 142.38 | 59.79 |
| High | 0.2004 | 207.30 | 357.46 | 142.38 | 59.80 |
| Low | 0.1900 | 205.30 | 351.24 | 139.76 | 58.66 |
| Latest | 0.2004 | 205.62 | 353.24 | 140.27 | 58.82 |
| Change | +0.0104 | +0.63 | -2.36 | -1.82 | -0.65 |
| % Change | +5.47% | +0.31% | -0.66% | -1.28% | -1.09% |
| Volume | 23,040 | 407,249 | 308,811 | 613,054 | 1,064,501 |
| 20-Day Average Volume | 12,510 | 1,803,101 | 2,641,256 | 5,706,829 | 12,989,861 |
| Previous Close | 0.1900 | 204.99 | 355.60 | 142.09 | 59.47 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.2141 | 193.85 | 352.09 | 139.92 | 59.06 |
| 20-Day Raw Stochastic | 27.27% | 93.74% | 52.19% | 49.62% | 44.85% |
| 20-Day Relative Strength | 43.48 | 61.05 | 49.24 | 49.92 | 50.02 |
| Weighted Alpha | -64.94 | +54.86 | +25.30 | +35.85 | +22.89 |
| Today's Opinion | 8% Buy | 88% Buy | 56% Buy | 56% Buy | 48% Buy |
| Previous Opinion | 8% Buy | 88% Buy | 56% Buy | 56% Buy | 64% Buy |
| Last Month's Opinion | 40% Buy | 64% Buy | 100% Buy | 88% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.00% since 04/01/26 | +1.11% since 04/02/26 | +1.99% since 04/02/26 | +0.92% since 04/02/26 | -0.94% since 04/02/26 |
| Low | 0.1610 on 04/02/26 | 196.95 on 04/07/26 | 335.06 on 04/07/26 | 137.15 on 04/07/26 | 57.65 on 04/07/26 |
| High | 0.2289 on 04/08/26 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 59.79 on 04/10/26 |
| 1-Month | |||||
| %Chg | -17.43% since 03/09/26 | +5.51% since 03/10/26 | -5.48% since 03/10/26 | -5.09% since 03/10/26 | -1.81% since 03/10/26 |
| Low | 0.1600 on 03/27/26 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 133.89 on 03/30/26 | 56.45 on 03/24/26 |
| High | 0.2700 on 03/12/26 | 207.30 on 04/10/26 | 380.14 on 03/11/26 | 149.30 on 03/11/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | -28.36% since 01/09/26 | +8.68% since 01/09/26 | +8.82% since 01/09/26 | +16.43% since 01/09/26 | +5.69% since 01/09/26 |
| Low | 0.1500 on 02/04/26 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 119.63 on 01/12/26 | 53.54 on 01/21/26 |
| High | 0.3000 on 01/12/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +26.67% since 10/09/25 | +21.70% since 10/10/25 | +22.31% since 10/10/25 | +20.33% since 10/10/25 | +34.30% since 10/10/25 |
| Low | 0.1257 on 01/05/26 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 0.3000 on 01/12/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,509 | 317,920,640 | 191,911,984 | 176,365,248 | 121,421,984 |
| Shares Outstanding, K | 7,940 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -24,950,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -680,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.71 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.15 on 11/19/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/11/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 22.30 | 16.01 | 17.37 | 9.63 |